E.E. Geduld’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

E.E. Geduld’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-10,000	Closed	-$200K	–	378
2014 Q1	$200K	Sell	10,000 -10,000	-50%	-$194K	0.11%	181
2013 Q4	$336K	Buy	+20,000	New	+$277K	0.16%	142

Other funds holding ANAC

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Westfield Capital Management

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

E.E. Geduld's ANAC Position: Q2 2014 in Review

E.E. Geduld sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2014, closing a stake of 10,000 shares — an estimated $200K sold.

E.E. Geduld first reported a position in ANAC in Q4 2013 and held it in 2 quarters. The position peaked at $336K in Q4 2013. 107 funds tracked by Wall St. Rank hold ANAC as of Q2 2014.

E.E. Geduld reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2014 after selling out during the quarter.
E.E. Geduld sold 10,000 ANACOR PHARMACEUTICALS INC COM shares in Q2 2014, an estimated $200K.
E.E. Geduld first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2013 and held it in 2 quarters.
E.E. Geduld's ANACOR PHARMACEUTICALS INC COM position peaked at $336K in Q4 2013.
107 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2014.

Based on E.E. Geduld's 13F filing for Q2 2014, filed 4 Aug 2014.